PDCD1 and neoplasm: This study displayed enhanced anti‐tumour activity in vitro and in vivo, outperforming currently used CAR‐T cells and PD‐1 blocking monoclonal antibody treatments, thus highlighting the importance of localized delivery of PD‐1 blockers.170